<DOC>
	<DOCNO>NCT00358930</DOCNO>
	<brief_summary>This Phase 2 , multi-center , open label study ARQ 501 patient locally advance , recurrent metastatic squamous cell cancer head neck ( SCCHN ) .</brief_summary>
	<brief_title>A Study ARQ 501 Patients With Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Beta-lapachone</mesh_term>
	<criteria>1 . Able provide sign date informed consent document prior studyspecific screening procedure . 2 . Histologically cytologically confirm locally advance , recurrent metastatic SCCHN . 3 . Measurable disease per RECIST . 4 . ≥ 18 year old . 5 . Karnofsky performance status ( KPS ) ≥ 70 % . 6 . Male female patient childproducing potential must agree use contraception avoidance pregnancy measure study 30 day last infusion ARQ 501 . 7 . Hemoglobin ( Hgb ) ≥ 10 g/dL . 8 . Absolute neutrophil count ( ANC ) ≥ 1.5 x 10^9/L ( ≥ 1,500/mm³ ) . 9 . Platelet count ≥ 100 x 10^9/L ( ≥ 100,000/mm³ ) . 10 . Total bilirubin less equal 1.5 x upper limit normal ( ULN ) less equal 3.0 x ULN metastatic liver disease . 11 . Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) less equal 2.5 x ULN le equal 5.0 x ULN metastatic liver disease . 12 . Creatinine le equal 1.5 x ULN . 1 . Primary tumor nasopharyngeal origin . 2 . Eligible curative surgery radiotherapy . 3 . Received three systemic anticancer regimen . 4 . Have active , uncontrolled systemic infection consider opportunistic , life threaten clinically significant time treatment . 5 . Have receive anticancer chemotherapy , immunotherapy , radiotherapy , investigational agent within three week first infusion . 6 . Surgery within two week first infusion . 7 . Have symptomatic untreated central nervous system ( CNS ) involvement . 8 . Are pregnant lactating . 9 . Previous exposure ARQ 501 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>squamous cell carcinoma head neck</keyword>
</DOC>